{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-15",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Navi Mumbai",
      "state": "N/A",
      "country": "India",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "99312",
      "recalling_firm": "Reliance Life Sciences Private Limited",
      "address_1": "Ttc Area Of Midc",
      "address_2": "R - 282 Dhirubhai Ambani Life Sciences Centre; Thane Belapur Road",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0674-2026",
      "product_description": "Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous  and Intravenous Use, Rx only,  Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0857-01",
      "product_quantity": "8,001 vials",
      "reason_for_recall": "Lack of Sterility Assurance",
      "recall_initiation_date": "20260624",
      "center_classification_date": "20260708",
      "report_date": "20260715",
      "code_info": "Lot, expiry:            RAZM0425A  Jun 30, 2027;   RAZM0525A Jun 30, 2027;   RAZM0725A Jun 30, 2027;   RAZM0825A Jun 30, 2027;   RAZM0925A Jul 31, 2027;   RAZM1125A Jul 31, 2027;   RAZM1225A Jul 31, 2027;   RAZM1425A Jul 31, 2027;   RAZM1525A Jul 31, 2027;   RAZM1625A Aug 31, 2027;   RAZM1725A Aug 31, 2027;   RAZM2025A Sep 30, 2027"
    }
  ]
}